Chimera Investment (NYSE:CIM - Get Free Report)'s stock had its "hold (c-)" rating reiterated by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.
A number of other research firms also recently issued reports on CIM. Keefe, Bruyette & Woods reduced their price target on shares of Chimera Investment from $16.50 to $15.00 and set a "market perform" rating on the stock in a research report on Thursday, July 10th. Wall Street Zen lowered shares of Chimera Investment from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Finally, UBS Group boosted their price objective on shares of Chimera Investment from $15.00 to $16.00 and gave the stock a "buy" rating in a research report on Thursday, July 10th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $15.50.
Check Out Our Latest Research Report on CIM
Chimera Investment Stock Up 0.3%
NYSE CIM traded up $0.04 on Wednesday, hitting $13.06. The stock had a trading volume of 444,256 shares, compared to its average volume of 686,138. Chimera Investment has a 52-week low of $9.85 and a 52-week high of $16.27. The company has a debt-to-equity ratio of 4.47, a current ratio of 4.14 and a quick ratio of 4.14. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of 10.37 and a beta of 1.85. The business's fifty day moving average price is $13.80 and its 200 day moving average price is $13.31.
Chimera Investment (NYSE:CIM - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.07). The company had revenue of $66.01 million for the quarter, compared to analyst estimates of $83.89 million. Chimera Investment had a return on equity of 7.28% and a net margin of 21.93%. Equities research analysts anticipate that Chimera Investment will post 1.57 earnings per share for the current year.
Institutional Investors Weigh In On Chimera Investment
A number of institutional investors and hedge funds have recently bought and sold shares of CIM. Manning & Napier Advisors LLC boosted its stake in shares of Chimera Investment by 50.0% in the first quarter. Manning & Napier Advisors LLC now owns 150,000 shares of the real estate investment trust's stock worth $1,924,000 after buying an additional 50,000 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Chimera Investment by 18.4% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 17,529 shares of the real estate investment trust's stock worth $225,000 after buying an additional 2,730 shares during the last quarter. Cadent Capital Advisors LLC raised its stake in Chimera Investment by 23.9% during the 1st quarter. Cadent Capital Advisors LLC now owns 215,712 shares of the real estate investment trust's stock valued at $2,768,000 after acquiring an additional 41,679 shares during the last quarter. Graham Capital Management L.P. raised its stake in Chimera Investment by 29.1% during the 1st quarter. Graham Capital Management L.P. now owns 97,838 shares of the real estate investment trust's stock valued at $1,255,000 after acquiring an additional 22,048 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Chimera Investment by 8.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 844,590 shares of the real estate investment trust's stock worth $10,836,000 after purchasing an additional 67,362 shares during the period. 48.44% of the stock is owned by institutional investors.
Chimera Investment Company Profile
(
Get Free Report)
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.